Cytosorbents Corp

Following third quarter earnings, analysts are bullish on immunotherapy company Cytosorbents Corp (NASDAQ:CTSO) and EnteroMedics Inc (NASDAQ:ETRM) thanks to the companies’ cutting edge treatments. …

Recently, various executives have taken part in insider selling activity for the stocks of Athersys, Inc.(NASDAQ:ATHX), Neuralstem, Inc.

Recently, various executives have taken part in insider trading activity for the stocks of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Celgene Corporation (NASDAQ:CELG), Cytosorbents Corp (NASDAQ:CTSO), and Amedica Corporation (NASDAQ:AMDA). Synergy Pharmaceuticals Inc …

In a research report published Monday, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on shares of Cytosorbents Corp (NASDAQ:CTSO) with a $25 price …

Recently, various executives have taken part in insider selling activity for the stocks of GoPro Inc (NASDAQ:GPRO), Qorvo Inc (NASDAQ:QRVO), InvenSense Inc (NYSE:INVN), and Cytosorbents …

Brean Capital analyst Jonathan Aschoff came out today with a few insights on Cytosorbents Corp (NASDAQ:CTSO), after the company released its first-quarter results last week. …

In a research report released Wednesday, MLV analyst Raghuram Selvaraju reiterated a Buy rating on Cytosorbents Corp (NASDAQ:CTSO) with a $28 price target, which …

Brean Capital analyst Jonathan Aschoff weighed in today with a few insights on Cytosorbents Corp (NASDAQ:CTSO), after hosting management meetings with the company yesterday. The analyst rates …

MLV analyst Raghuram Selvaraju came out today with an extremely bullish call on Cytosorbents Corp (NASDAQ:CTSO), initiating a Buy rating and a $30 price target, …

Brean Capital analyst Jonathan Aschoff was out pounding the table on Cytosorbents Corp (NASDAQ:CTSO) Thursday, reiterating a Buy rating and price target of $25, …